Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Cancer
-
-
-
-
-
-
NAD Kinase (catalytic domain) (human) (rec.) (His) (highly active)
AG-40T-0090 AG-40T-0090-C050 50 µg CHF 540.00 -
-
-
Nampt (Visfatin/PBEF) (human) (rec.) (His) (BULK)
AG-40A-0018AA AG-40A-0018AA-C500 500 µg CHF 2’800.00![Measurement of NAMPT enzymatic activity was performed as described previously [G.C. Elliott, et al.; Anal Biochem 107, 199 (1980)]. The recombinant Nampt was diluted in assay buffer and 10μl per 50μl reaction mix were applied in the reaction mix (20](https://adipogen.com/media/catalog/product/cache/be9249d907792254897dc476f14d8e2a/a/g/ag-40a-0018aa_h-nampt_visfatin_-his-enzymatic-activity.png)
-
![Measurement of NAMPT enzymatic activity was performed as described previously [G.C. Elliott, et al.; Anal Biochem 107, 199 (1980)]. The recombinant Nampt was diluted in assay buffer and 10μl per 50μl reaction mix were applied in the reaction mix (20](https://adipogen.com/media/catalog/product/cache/be9249d907792254897dc476f14d8e2a/a/g/ag-40a-0018_h-nampt_visfatin_-his-enzymatic-activity.png)